USFDA grants orphan drug and pediatric exclusivities for Cresemba for aspergillosis and mucormycosis in children
CRESEMBA receives seven years and six months of US market exclusivity for these pediatric indications
CRESEMBA receives seven years and six months of US market exclusivity for these pediatric indications
Women emerge as the cornerstone of this monumental undertaking
The plan is to set up an ultramodern Solvent Recovery Plant for third party purposes
India has reached to nearly 6,000 bio-startups from 50 in the past 10 years
Nectar Lifesciences has clarified that the company has no relation/connection/ association or link of any nature with the Nectar Herbs and Drugs
Earlier, he worked with Cadila Pharmaceuticals Limited, Cipla, Alkem Laboratories, and Wockhardt, and started his career with Novartis
The Convocation ceremony was organized for students skilled and certified in Ayush
EDQM conducts GMP inspection of SMS Pharmaceuticals’ API facility
The production started from its greenfield manufacturing facility at Aurangabad in Maharashtra
Subscribe To Our Newsletter & Stay Updated